WallStreetZenWallStreetZen

NASDAQ: ILMN
Illumina Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ILMN

Based on 12 analysts offering 12 month price targets for Illumina Inc

Min Forecast
$80.00-15.9%
Avg Forecast
$112.75+18.53%
Max Forecast
$185.00+94.49%

Should I buy or sell ILMN stock?

Based on 12 analysts offering ratings for Illumina Inc.

Hold
Strong Buy
3 analysts 25%
Buy
2 analysts 16.67%
Hold
5 analysts 41.67%
Sell
0 analysts 0%
Strong Sell
2 analysts 16.67%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their ILMN stock forecasts and price targets.

ILMN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-04Find Out Why
lockedlocked$00.00+00.00%2025-08-01Find Out Why
lockedlocked$00.00+00.00%2025-08-01Find Out Why
lockedlocked$00.00+00.00%2025-08-01Find Out Why
lockedlocked$00.00+00.00%2025-07-28Find Out Why
ScotiaBank
Bottom 3%
3
HoldDowngrades$125.00+31.41%2025-07-11
Citigroup
Top 19%
82
Strong SellDowngrades$80.00-15.90%2025-07-09
Evercore ISI Group
Bottom 3%
3
BuyMaintains$128.00+34.57%2025-07-08
Stephens & Co.
Bottom 5%
5
Strong BuyReiterates$105.00+10.39%2025-05-20
Piper Sandler
Top 10%
91
Strong BuyMaintains$185.00+94.49%2025-05-15

1 of 2

Forecast return on equity

Is ILMN forecast to generate an efficient return?

Company
37.93%
Industry
12.36%
Market
-20.87%
ILMN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ILMN forecast to generate an efficient return on assets?

Company
14.07%
Industry
12.72%
ILMN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ILMN earnings per share forecast

What is ILMN's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$4.50-43.13%
Avg 2 year Forecast
$4.73-40.3%
Avg 3 year Forecast
$5.57-29.64%
ILMN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ILMN revenue forecast

What is ILMN's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$4.3B-0.53%
Avg 2 year Forecast
$4.4B+2.14%
Avg 3 year Forecast
$4.7B+9.17%
ILMN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ILMN earnings growth forecast

How is ILMN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
-21.47%
Industry
20.82%
Market
19.35%
ILMN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ILMN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ILMN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ILMN revenue growth forecast

How is ILMN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
1.71%
Industry
4.81%
Market
11.89%
ILMN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ILMN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ILMN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
ILMN$95.12$112.75+18.53%Hold
MEDP$490.64$424.10-13.56%Hold
ICLR$175.00$201.75+15.29%Buy
WAT$295.39$364.00+23.23%Buy
EXAS$53.94$60.82+12.75%Buy
View Top Diagnostic & Research Stocks

Illumina Stock Forecast FAQ

Is Illumina Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: ILMN) stock is to Hold ILMN stock.

Out of 12 analysts, 3 (25%) are recommending ILMN as a Strong Buy, 2 (16.67%) are recommending ILMN as a Buy, 5 (41.67%) are recommending ILMN as a Hold, 0 (0%) are recommending ILMN as a Sell, and 2 (16.67%) are recommending ILMN as a Strong Sell.

If you're new to stock investing, here's how to buy Illumina stock.

What is ILMN's earnings growth forecast for 2025-2027?

(NASDAQ: ILMN) Illumina's forecast annual earnings growth rate of -21.47% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 20.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.35%.

Illumina's earnings in 2025 is $1,258,000,000.On average, 7 Wall Street analysts forecast ILMN's earnings for 2025 to be $692,310,910, with the lowest ILMN earnings forecast at $680,891,000, and the highest ILMN earnings forecast at $699,335,000. On average, 10 Wall Street analysts forecast ILMN's earnings for 2026 to be $726,693,600, with the lowest ILMN earnings forecast at $613,263,000, and the highest ILMN earnings forecast at $771,574,000.

In 2027, ILMN is forecast to generate $856,493,250 in earnings, with the lowest earnings forecast at $809,999,000 and the highest earnings forecast at $886,849,000.

What is ILMN's revenue growth forecast for 2025-2027?

(NASDAQ: ILMN) Illumina's forecast annual revenue growth rate of 1.71% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.89%.

Illumina's revenue in 2025 is $4,284,000,000.On average, 5 Wall Street analysts forecast ILMN's revenue for 2025 to be $654,962,578,500, with the lowest ILMN revenue forecast at $653,071,300,000, and the highest ILMN revenue forecast at $658,758,200,000. On average, 6 Wall Street analysts forecast ILMN's revenue for 2026 to be $672,536,175,400, with the lowest ILMN revenue forecast at $664,445,100,000, and the highest ILMN revenue forecast at $678,923,947,400.

In 2027, ILMN is forecast to generate $718,853,055,600 in revenue, with the lowest revenue forecast at $695,953,600,000 and the highest revenue forecast at $729,609,750,100.

What is ILMN's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ILMN) forecast ROA is 14.07%, which is higher than the forecast US Diagnostics & Research industry average of 12.72%.

What is ILMN's Price Target?

According to 12 Wall Street analysts that have issued a 1 year ILMN price target, the average ILMN price target is $112.75, with the highest ILMN stock price forecast at $185.00 and the lowest ILMN stock price forecast at $80.00.

On average, Wall Street analysts predict that Illumina's share price could reach $112.75 by Aug 4, 2026. The average Illumina stock price prediction forecasts a potential upside of 18.53% from the current ILMN share price of $95.12.

What is ILMN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ILMN) Illumina's current Earnings Per Share (EPS) is $7.92. On average, analysts forecast that ILMN's EPS will be $4.50 for 2025, with the lowest EPS forecast at $4.43, and the highest EPS forecast at $4.55. On average, analysts forecast that ILMN's EPS will be $4.73 for 2026, with the lowest EPS forecast at $3.99, and the highest EPS forecast at $5.02. In 2027, ILMN's EPS is forecast to hit $5.57 (min: $5.27, max: $5.77).

What is ILMN's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ILMN) forecast ROE is 37.93%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.